Settled Heart Valve Lawsuit: Medtronic to Pay Edwards: Edwards Lifesciences’ Sapien XT beat out Medtronic’s CoreValve

Reporter: Aviva Lev-Ari, PhD, RN

UPDATED on 1/16/2019

Boston Scientific, Edwards Lifesciences Agree To Global Litigation Settlement

All patent litigation between the companies to be dismissed

January 15, 2019 — Boston Scientific Corp. and Edwards Lifesciences Corp. announced that the companies have reached an agreement to settle all outstanding patent disputes between the companies in all venues around the world. All pending cases or appeals in courts and patent offices between the two companies will be dismissed, and the parties will not litigate patent disputes related to current portfolios of transcatheter aortic valves, certain mitral valve repair devices and left atrial appendage closure devices. Any injunctions currently in place will be lifted.

Under the terms of the agreement, Edwards has made a one-time payment to Boston Scientific of $180 million. No further royalties will be owed by either party under the agreement. All other terms remain confidential.

On Dec. 11, a jury in the U.S. District Court for the District of Delaware determined that the Boston Scientific U.S. patent 8,992,608 is valid and that Edwards Lifesciences’ Sapien 3 aortic valve infringes this patent. The court ruled at that time that Edwards owed Boston Scientific $35 million in infringement damages through the end of 2016. The jury also found that the Boston Scientific Lotus aortic valve system does not infringe Edwards’ Spenser patents U.S. 7,510,575, U.S. 9,168,133, or U.S. 9,339,383.

Read the article Boston Scientific Prevails in U.S. Edwards Lifesciences Litigation

For more information: www.bostonscientific.com, www.edwards.com

See evolution of the case

UPDATED: Transcatheter Valve Competition in the United States: Medtronic CoreValve infringes on Edwards Lifesciences Corp. Transcatheter Device Patents

Curator: Aviva Lev-Ari, PhD, RN

http://pharmaceuticalintelligence.com/2014/01/26/transcatheter-valve-competition-in-the-united-states-medtronic-corevalve-infringes-on-edwards-lifesciences-corp-transcatheter-device-patents/

Medtronic to Pay Edwards to Settle Heart Valve Lawsuit

By Michelle Fay Cortez  May 20, 2014 4:06 PM ET

A preliminary injunction was granted by the federal court in Wilmington, Delaware, on… Read More

Medtronic Inc. (MDT), the world’s biggest maker of heart-rhythm devices, will pay Edwards Lifesciences Corp. (EW) at least $1.1 billion to settle a patent dispute over their minimally invasive valves.

Edwards will receive $750 million upfront and royalties of at least $40 million a year through 2022, Minneapolis-based Medtronic said in a statement. The companies agreed to dismiss all pending litigation over the valves and refrain from filing additional lawsuits for the eight years of the agreement.

The settlement will give Medtronic free rein after years of litigation to develop the market for the valves that it estimates at $2 billion to $2.5 billion a year. A federal court last month had granted, then stayed, a preliminary injunction that would have prevented Medtronic from selling CoreValve, used to treat aortic stenosis, in the U.S. because it infringed a patent held by Irvine, California-based Edwards. Edwards sells the Sapien valve.

“We see this settlement as a clear financial positive for Edwards,” David Roman, an analyst at Goldman Sachs Group Inc., said in a note. He estimated that royalty payments of $40 million to $60 million would mean a earnings boost of 24 to 36 cents a share this year.

Edwards declined 1.5 percent to $85.15 at the close in New York. Medtronic fell 1.5 percent to $59.41.

 

SOURCE

http://www.bloomberg.com/news/2014-05-20/medtronic-to-pay-edwards-to-settle-heart-valve-lawsuit.html

First head-to-head trial finds Edwards’ TAVR superior to Medtronic’s

See on Scoop.it – Cardiovascular and vascular imaging

Edwards Lifesciences’ Sapien XT beat out Medtronic’s CoreValve in the first head-to-head comparison of the two firms’ competing transcatheter aortic valve replacements (TAVR).

See on www.fiercemedicaldevices.com